Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
2017
Kountouras, J., Polyzos S. A., Zeglinas C., Tzathas C., Nikolaidis N., Vardaka E., et al. (2017).  Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort.. Gastrointest Endosc. 85(2), 462-463.
Kountouras, J., Boziki M., Polyzos S. A., Katsinelos P., Gavalas E., Zeglinas C., et al. (2017).  Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis.. Free Radic Res. 51(1), 73-79.
Polyzos, S. A., Duntas L., & Bollerslev J. (2017).  The intriguing connections of leptin to hyperparathyroidism.. Endocrine. 57(3), 376-387.
Polyzos, S. A., & Mantzoros C. S. (2017).  Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.. Metabolism. 72, A4-A10.
Anastasilakis, A. D., Polyzos S. A., Tsoli M., Papatheodorou A., Kokkoris P., Kaltsas G., et al. (2017).  Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity.. Metabolism. 71, 198-201.
Polyzos, S. A., Bugianesi E., Kountouras J., & Mantzoros C. S. (2017).  Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.. Metabolism. 66, 64-68.
Kazakos, E. I., Kountouras J., Polyzos S. A., & Deretzi G. (2017).  Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system.. Med Hypotheses. 102, 33-36.
Kountouras, J., Polyzos S. A., Katsinelos P., Kotronis G., & Doulberis M. (2017).  Obesity and the nervous system: more questions.. Lancet Neurol. 16(10), 772-773.
Polyzos, S. A., Makras P., Anastasilakis A. D., Mintziori G., Kita M., Papatheodorou A., et al. (2017).  Periostin and sclerostin levels in juvenile Paget's disease.. Clin Cases Miner Bone Metab. 14(2), 269-271.
Kountouras, C., Polyzos S. A., Stergiopoulos C., Katsinelos P., Tzivras D., Zavos C., et al. (2017).  A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke.. Sleep Med. 34, 256.
2016
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Triantafyllou G. Α., & Mantzoros C. S. (2016).  Activin A and follistatin in patients with nonalcoholic fatty liver disease.. Metabolism. 65(10), 1550-8.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2016).  Adipokines in nonalcoholic fatty liver disease.. Metabolism. 65(8), 1062-79.
Polyzos, S. A., & Mantzoros C. S. (2016).  Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.. Metabolism. 65(9), 1297-306.
Anastasilakis, A. D., Polyzos S. A., Skouvaklidou E. C., Kynigopoulos G., Saridakis Z. G., Apostolou A., et al. (2016).  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.. Metabolism. 65(10), 1459-65.
Polyzos, S. A., Aronis K. N., Kountouras J., Raptis D. D., Vasiloglou M. F., & Mantzoros C. S. (2016).  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.. Diabetologia. 59(1), 30-43.
Polyzos, S. A., Anastasilakis A. D., Kountouras J., Makras P., Papatheodorou A., Kokkoris P., et al. (2016).  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.. J Bone Miner Metab. 34(4), 447-56.
Polyzos, S. A., & Terpos E. (2016).  Clinical vertebral fractures following denosumab discontinuation.. Endocrine. 54(1), 271-272.
Nikolaidis, N., Polyzos S. A., Giouleme O., Katsinelos P., Eugenidis N., Zeglinas C., et al. (2016).  Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation.. Med Hypotheses. 95, 34.
Mintziori, G., & Polyzos S. A. (2016).  Emerging and future therapies for nonalcoholic steatohepatitis in adults.. Expert Opin Pharmacother. 17(14), 1937-46.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Triantafilli M., et al. (2016).  Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.. Leuk Lymphoma. 57(3), 577-84.
Kountouras, J., Polyzos S. A., Zeglinas C., Katsinelos P., Giorgakis N., Vardaka E., et al. (2016).  Helicobacter pylori infection and oesophageal adenocarcinoma.. Cancer Epidemiol. 42, 206-7.
Polyzos, S. A., & Kountouras J. (2016).  Homocysteine in nonalcoholic steatohepatitis: A reply.. Eur J Intern Med. 35, e40-e41.
Makras, P., Polyzos S. A., & Anastasilakis A. D. (2016).  Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.. J Clin Endocrinol Metab. 101(9), L89-90.
Polyzos, S. A., & Mantzoros C. S. (2016).  Nonalcoholic fatty future disease.. Metabolism. 65(8), 1007-16.
Polyzos, S. A., & Anastasilakis A. D. (2016).  Periostin on the road to nonalcoholic fatty liver disease.. Endocrine. 51(1), 4-6.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές